Autophagy blockade mechanistically links proton pump inhibitors to worsened diabetic nephropathy and aborts the renoprotection of metformin/enalapril
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Autophagy blockade mechanistically links proton pump inhibitors to worsened diabetic nephropathy and aborts the renoprotection of metformin/enalapril
Authors
Keywords
Lansoprazole, Metformin, Podocytes, LC3, p62, Oxidative stress
Journal
LIFE SCIENCES
Volume 265, Issue -, Pages 118818
Publisher
Elsevier BV
Online
2020-12-02
DOI
10.1016/j.lfs.2020.118818
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differential Modulation of Autophagy Contributes to the Protective Effects of Resveratrol and Co-enzyme Q10 in Photoaged Mice
- (2020) Dalia Kamal Mostafa et al. Current Molecular Pharmacology
- Metformin prevents cell tumorigenesis through autophagy-related cell death
- (2019) Mauro De Santi et al. Scientific Reports
- High Dose Vitamin E Attenuates Diabetic Nephropathy via Alleviation of Autophagic Stress
- (2019) Yuxue Zhao et al. Frontiers in Physiology
- Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study
- (2019) Emily Hart et al. PHARMACOTHERAPY
- The Effect of Proton Pump Inhibitors on Glycemic Control in Patients with Type 2 Diabetes
- (2019) Kelly Villegas et al. Metabolic Syndrome and Related Disorders
- Podocytes and autophagy: a potential therapeutic target in lupus nephritis
- (2019) Xu-Jie Zhou et al. Autophagy
- The proton pump inhibitor pantoprazole disrupts protein degradation systems and sensitizes cancer cells to death under various stresses
- (2018) Yu Cao et al. Cell Death & Disease
- Proton pump inhibitors use and risk of chronic kidney disease in diabetic patients
- (2018) Hsun Yang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Metformin attenuates diabetes-induced tau hyperphosphorylation in vitro and in vivo by enhancing autophagic clearance
- (2018) Jin-Liang Chen et al. EXPERIMENTAL NEUROLOGY
- mTORC1 as the main gateway to autophagy
- (2017) Yoana Rabanal-Ruiz et al. Essays in Biochemistry
- 25 Years of Proton Pump Inhibitors: A Comprehensive Review
- (2017) Daniel S. Strand et al. Gut and Liver
- Proton Pump Inhibitors, Nephropathy, and Cardiovascular Disease in Type 2 Diabetes: The Fremantle Diabetes Study
- (2017) Timothy M E Davis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury
- (2017) Yan Xie et al. KIDNEY INTERNATIONAL
- Metformin extends C. elegans lifespan through lysosomal pathway
- (2017) Jie Chen et al. eLife
- Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy
- (2017) Na Liu et al. Journal of Diabetes Research
- Transcription factor EB: from master coordinator of lysosomal pathways to candidate therapeutic target in degenerative storage diseases
- (2016) Marco Sardiello Annals of the New York Academy of Sciences
- Pleiotropic protective effects of Vitamin D against high fat diet-induced metabolic syndrome in rats: One for all
- (2016) Dalia K. Mostafa et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- PPIs and kidney disease: from AIN to CKD
- (2016) Dennis G. Moledina et al. JOURNAL OF NEPHROLOGY
- Proton pump inhibitor prescribing patterns in the UK: a primary care database study
- (2016) Fatmah Othman et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Proton pump inhibitors are associated with increased risk of development of chronic kidney disease
- (2016) Pradeep Arora et al. BMC Nephrology
- Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
- (2016) Benjamin Lazarus et al. JAMA Internal Medicine
- Proton Pump Inhibitors Display Antitumor Effects in Barrett's Adenocarcinoma Cells
- (2016) Eduardo Chueca et al. Frontiers in Pharmacology
- Renal biomarkers of male and female Wistar rats (Rattus norvegicus) undergoing renal ischemia and reperfusion
- (2015) Telma Bazzano et al. Acta Cirurgica Brasileira
- Mechanisms of Autophagy
- (2015) Nobuo N. Noda et al. Annual Review of Biophysics
- Emerging role of podocyte autophagy in the progression of diabetic nephropathy
- (2015) Mako Yasuda-Yamahara et al. Autophagy
- Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis
- (2015) Olivia Lenoir et al. Autophagy
- Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors
- (2015) Man Yu et al. CANCER SCIENCE
- p62 links autophagy and Nrf2 signaling
- (2015) Tao Jiang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Autophagy-Lysosome Pathway in Renal Tubular Epithelial Cells Is Disrupted by Advanced Glycation End Products in Diabetic Nephropathy
- (2015) Wei Jing Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Autophagy: A Novel Therapeutic Target for Diabetic Nephropathy
- (2015) Shinji Kume et al. Diabetes & Metabolism Journal
- Multimorbidities and Overprescription of Proton Pump Inhibitors in Older Patients
- (2015) Anne Delcher et al. PLoS One
- Autophagy protects renal tubular cells against cyclosporine toxicity
- (2014) Nicolas Pallet et al. Autophagy
- Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
- (2014) Daniel J. Klionsky et al. Autophagy
- Autophagy in diabetic nephropathy
- (2014) Yan Ding et al. JOURNAL OF ENDOCRINOLOGY
- Proton pump inhibitors (PPIs) impact on tumour cell survival, metastatic potential and chemotherapy resistance, and affect expression of resistance-relevant miRNAs in esophageal cancer
- (2014) Kirsten Lindner et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Thioredoxin-interacting protein mediates dysfunction of tubular autophagy in diabetic kidneys through inhibiting autophagic flux
- (2014) Chunling Huang et al. LABORATORY INVESTIGATION
- The Proton Pump Inhibitor Lansoprazole Improves the Skeletal Phenotype in Dystrophin Deficient mdx Mice
- (2013) Arpana Sali et al. PLoS One
- KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update
- (2012) AMERICAN JOURNAL OF KIDNEY DISEASES
- Guidelines for the use and interpretation of assays for monitoring autophagy
- (2012) Daniel J. Klionsky et al. Autophagy
- Intracellular Proton Pumps as Targets in Chemotherapy: V-ATPases and Cancer
- (2012) Agustin Hernandez et al. CURRENT PHARMACEUTICAL DESIGN
- Improvement of Cardiac Functions by Chronic Metformin Treatment Is Associated With Enhanced Cardiac Autophagy in Diabetic OVE26 Mice
- (2011) Z. Xie et al. DIABETES
- Methods in Mammalian Autophagy Research
- (2010) Noboru Mizushima et al. CELL
- Pathologic Classification of Diabetic Nephropathy
- (2010) T. W. C. Tervaert et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway
- (2010) Ana I. Morales et al. KIDNEY INTERNATIONAL
- A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction between Keap1 and p62
- (2010) A. Lau et al. MOLECULAR AND CELLULAR BIOLOGY
- A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy
- (2008) I. H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started